Carre Emmanuel - EDAP TMS Chief Officer
| EDAP Stock | USD 2.46 0.23 10.31% |
Executive
Carre Emmanuel is Chief Officer of EDAP TMS SA
| Address | Parc dActivites la Poudrette-Lamartine, Lyon, France, 69120 |
| Phone | 33 4 72 153 150 |
| Web | https://www.edap-tms.com |
EDAP TMS Management Efficiency
The company has return on total asset (ROA) of (0.1224) % which means that it has lost $0.1224 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4307) %, meaning that it created substantial loss on money invested by shareholders. EDAP TMS's management efficiency ratios could be used to measure how well EDAP TMS manages its routine affairs as well as how well it operates its assets and liabilities. As of 12/18/2024, Return On Tangible Assets is likely to grow to -0.23. In addition to that, Return On Capital Employed is likely to grow to -0.29. At this time, EDAP TMS's Non Current Liabilities Total is relatively stable compared to the past year. As of 12/18/2024, Change To Liabilities is likely to grow to about 1.4 M, while Total Current Liabilities is likely to drop slightly above 16.2 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Ron Lagerquist | Avita Medical | N/A | |
| Philip Corrin | Inogen Inc | N/A | |
| JD PMP | Avita Medical | N/A | |
| Krishna Jhaveri | Inogen Inc | N/A | |
| Paul Andreassi | Inogen Inc | N/A | |
| Jennifer Boyer | Inogen Inc | N/A | |
| Grgoire Ramade | Inogen Inc | 54 | |
| David Fencil | Avita Medical | N/A | |
| Donna Shiroma | Avita Medical | 61 | |
| Katie Bush | Avita Medical | N/A | |
| Nicole Kelsey | Avita Medical | N/A | |
| Adrien Mithalal | Inogen Inc | N/A | |
| Kevin Smith | Inogen Inc | 53 | |
| Debbie Garner | Avita Medical | N/A | |
| Vijay Paliwal | Inogen Inc | N/A | |
| Terry Bromley | Avita Medical | N/A | |
| Jessica Ekeberg | Avita Medical | N/A | |
| David OToole | Avita Medical | 65 | |
| Rob Hall | Avita Medical | N/A | |
| MBA MD | Inogen Inc | 51 | |
| Matthew CPA | Apyx Medical | 55 | |
Management Performance
| Return On Equity | -0.43 | ||||
| Return On Asset | -0.12 |
EDAP TMS SA Leadership Team
Elected by the shareholders, the EDAP TMS's board of directors comprises two types of representatives: EDAP TMS inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EDAP. The board's role is to monitor EDAP TMS's management team and ensure that shareholders' interests are well served. EDAP TMS's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EDAP TMS's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Blandine Confort, Investor Relations Officer | ||
| Francois Dietsch, Global Officer | ||
| Ken Mobeck, Chief Officer | ||
| Frank Hyfte, VP Marketing | ||
| Marc Oczachowski, CEO and President of Edap Tms France Sas and President of Edap Technomed Inc | ||
| Ryan Rhodes, CEO Director | ||
| Carre Emmanuel, Chief Officer | ||
| JeanFrancois Bachelard, President Ltd | ||
| Frederic Pech, President France |
EDAP Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is EDAP TMS a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.43 | ||||
| Return On Asset | -0.12 | ||||
| Profit Margin | (0.35) % | ||||
| Operating Margin | (0.45) % | ||||
| Current Valuation | 62.19 M | ||||
| Shares Outstanding | 37.1 M | ||||
| Shares Owned By Institutions | 42.44 % | ||||
| Number Of Shares Shorted | 42.11 K | ||||
| Price To Earning | 107.40 X | ||||
| Price To Book | 1.85 X |
Pair Trading with EDAP TMS
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EDAP TMS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EDAP TMS will appreciate offsetting losses from the drop in the long position's value.Moving against EDAP Stock
| 0.78 | OM | Outset Medical | PairCorr |
| 0.75 | DOCS | Doximity | PairCorr |
| 0.71 | VREX | Varex Imaging Corp | PairCorr |
| 0.69 | DXCM | DexCom Inc | PairCorr |
| 0.68 | GH | Guardant Health | PairCorr |
The ability to find closely correlated positions to EDAP TMS could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EDAP TMS when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EDAP TMS - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling EDAP TMS SA to buy it.
The correlation of EDAP TMS is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EDAP TMS moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if EDAP TMS SA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EDAP TMS can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for EDAP Stock Analysis
When running EDAP TMS's price analysis, check to measure EDAP TMS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EDAP TMS is operating at the current time. Most of EDAP TMS's value examination focuses on studying past and present price action to predict the probability of EDAP TMS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EDAP TMS's price. Additionally, you may evaluate how the addition of EDAP TMS to your portfolios can decrease your overall portfolio volatility.